Shu-Chuan Chiang, MD
- 2Articles
- 5.8KReads1
- 2007–2010Active
- 11Collaborators
- 45Citations2
About
Shu-Chuan Chiang, MD, has published research focused on the treatment of schizophrenia and schizoaffective disorders, particularly examining antipsychotic medications such as risperidone, olanzapine, and aripiprazole. The work includes randomized controlled trials assessing efficacy and safety in managing neuroleptic-induced tardive dyskinesia and acute schizophrenia symptoms. Collaborations frequently include Hai-Gwo Hwu, Hung-Yu Chan, Ching-Jui Chang, Chiung-Hsu Chen, and Jiahn-Jyh Chen.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
